| Click here for STORY-PRODUCTION-TEAM DETAILS |
| Click here for PRIVATE EQUITY INVESTOR MESSAGE | CONTACT US |
A quick-reference overview of the project's core parameters for slate evaluation.
The Seraphim is budgeted within a range that reflects the current market for elevated, high-concept horror — large enough to deliver cinematic production value, disciplined enough to achieve strong returns at modest performance thresholds.
Final budget to be set at greenlight, commensurate with financing structure and distribution deal terms.
Actively seeking anchor commitments from producers, co-producers, and equity partners. Early commitments secure preferred terms.
Financing Structure (Proposed)
The production anticipates a multi-source capital structure typical of independent features in this budget tier. Potential components include:
Why This Budget Tier Works for Horror
Supernatural horror consistently over-performs at the $5M–$15M level. The budget allows for a professional cast and crew, practical and VFX elements, and a wide theatrical P&A push, while remaining well below the threshold where profitability requires blockbuster-scale results. The comparable films detailed in Section 04 demonstrate that this budget tier, when paired with strong IP, a compelling cast, and disciplined marketing, routinely yields 5–9x returns.
The following scenarios model potential revenue across the primary windows for a theatrically-released R-rated supernatural horror feature. Projections are based on comparable film performance and standard industry revenue-sharing models. All figures are illustrative and subject to final deal terms.
| Scenario | Domestic Theatrical | Intl. Theatrical | Streaming/Home | Est. Total Revenue | Net to Producers* |
|---|---|---|---|---|---|
| Upside Strong release, word-of-mouth run | $40M–$60M | $30M–$50M | $15M–$25M | $85M–$135M | $20M–$40M+ |
| Base Case Solid limited-wide release | $15M–$30M | $12M–$20M | $8M–$15M | $35M–$65M | $5M–$18M |
| Conservative Platform / niche release | $5M–$12M | $4M–$8M | $4M–$8M | $13M–$28M | Recoupment + modest upside |
*Net to producers after theatrical distribution fees (~35%), P&A costs, and production budget recoupment. Streaming rights negotiated independently from theatrical deal.
Streaming Value Drivers
SVOD demand for horror content remains among the strongest of any genre. A theatrically-proven R-rated supernatural horror feature with cast social reach will command competitive licensing fees from major platforms including Netflix, Prime Video, Max, and Shudder. Pre-sale or output deal negotiation is anticipated to begin concurrent with principal photography.
Ancillary Revenue
Additional revenue streams include international television sales, physical media (collector's editions perform well in horror), soundtrack licensing, and franchise/sequel rights — all of which represent meaningful upside beyond the primary theatrical and streaming windows.
The following films establish the financial and tonal landscape in which The Seraphim competes. Each demonstrates that R-rated supernatural horror, when executed with craft and a compelling premise, delivers exceptional returns at this budget level.
Supernatural family horror anchored by a strong ensemble cast and elevated direction. Premiered at Sundance; wide theatrical release via A24. The definitive modern benchmark for premium horror returns at this budget tier.
Supernatural / religious horror with strong international appeal. Demonstrates the global commercial power of the genre, particularly in European and Asian markets. Relevant tone comp for The Seraphim's thematic territory.
Supernatural horror originally designed for streaming, repositioned for theatrical upon positive test screenings — and a major box office overperformer as a result. Validates theatrical-first strategy for the genre at this budget level.
Elevated supernatural horror with a strong female lead and psychological depth. A conservative performance benchmark — even at this modest return, the budget tier remained viable. Strong streaming afterlife extended audience reach significantly.
Market Context
Horror is consistently the highest-margin genre in film. In 2025, horror dominated the box office — with titles including Final Destination: Bloodlines, The Conjuring: Last Rites, and The Black Phone 2 collectively generating hundreds of millions globally. Audience appetite for R-rated supernatural horror at the multiplex has never been stronger, and SVOD platforms continue to acquire the genre aggressively for their libraries.
The following represents the anticipated production and release schedule. All phases are subject to adjustment based on financing close date and distribution deal structure.
Script finalization, business plan distribution to distributors and producers, early investor meetings, talent packaging, and preliminary location scouting. Legal and IP documentation finalized through Quisenberry Law PLLC.
Anchor financing commitments secured. Director, key department heads, and remaining cast finalized. Location deals, production design, and technical prep completed. Shooting schedule locked.
Estimated 25–35 day shoot. Production will be located to maximize applicable film tax incentives. On-set production managed by Houston Creative Media Group, LLC in partnership with Wonder Peak Media.
Picture edit, VFX, color grade, sound mix, and score completion. Estimated post timeline of 4–6 months following picture wrap. Delivery of festival and distribution masters.
Target festival premiere in early 2027. Theatrical release to follow via distribution partner, with streaming window to open 90–120 days post-theatrical.
The Seraphim is positioned for a theatrical-first release strategy, followed by a premium streaming window. This approach maximizes revenue per window while using theatrical performance as leverage in streaming rights negotiations.
Wide or limited-wide release targeting 1,500–2,500 screens in North America. Distributor partnership to be confirmed upon financing close. Horror performs strongly in multiplexes year-round, with peak seasons in October and late January.
Territory-by-territory pre-sales via an appointed international sales agent. Primary targets: United Kingdom, Germany, France, Australia, Mexico, South Korea, and Japan — all proven markets for English-language supernatural horror.
Streaming rights to be negotiated independently from theatrical deal, targeting platforms including Netflix, Prime Video, Max, and Shudder. Theatrical track record will be used to maximize licensing fee. Window opens 90–120 days post-theatrical.
PVOD, digital rental/purchase, and physical media (Blu-ray). Horror collector's editions consistently outperform other genres in physical media. Soundtrack and score licensing for additional revenue.
Distributor Positioning
The Seraphim is suited for distributors with experience in elevated genre film — including A24, Neon, Lionsgate, Blumhouse Productions / Universal, Searchlight, and IFC Films. The project's cast social media reach provides a meaningful built-in marketing asset that reduces a distributor's audience acquisition costs.
The Seraphim is based on original screenplay material. The intellectual property is wholly owned by the production entity. No underlying rights clearances, adaptation rights, or third-party IP licenses are required for production or distribution.
Legal representation for chain of title, deal structuring, and rights management is provided by:
Rights Available
The following rights are available for licensing or outright acquisition as part of a distribution or production partnership: Worldwide theatrical, domestic theatrical, international theatrical (by territory), SVOD/AVOD/TVOD, physical media, television (broadcast and cable), sequel and franchise rights, and soundtrack/music rights.
E&O Insurance
Errors & Omissions insurance will be obtained prior to delivery as a standard condition of distribution. Title clearance and copyright registration will be completed as part of pre-production legal preparation.
Key below-the-line crew are currently being assembled in conjunction with the financing and pre-production process. Department head attachments — including Director of Photography, Production Designer, and Composer — will be confirmed and announced following the financing close.
Candidates are being evaluated with particular attention to genre experience, visual sensibility aligned with the project's tone, and prior credits in the $5M–$20M budget range. Crew attachment packages will be made available to confirmed financing and distribution partners upon request.
Current Key Attachments
A targeted festival run serves dual purposes: it generates critical credibility and press coverage that amplifies the theatrical campaign, and it creates a competitive acquisition environment among distributors. The festival-to-distribution pipeline has become the standard path for elevated horror, as demonstrated by Hereditary (Sundance → A24), The Night House (Sundance → Searchlight), and Talk to Me (Sundance → A24).
Awards Positioning
While horror is traditionally underrepresented in major awards categories, elevated supernatural horror has increasingly crossed into awards conversation — with Hereditary earning significant critical year-end recognition and A Quiet Place receiving an Academy Award nomination for Sound. The Seraphim's emphasis on performance, original score, and cinematography positions it for genre awards (Saturn Awards, Fangoria Chainsaw Awards) as well as broader critical recognition that supports theatrical positioning.
Press & Critical Strategy
A focused press strategy targeting major horror and genre publications — including Bloody Disgusting, Dread Central, Fangoria, and Rue Morgue — will run parallel to mainstream entertainment press outreach. Early screener access for key critics will be coordinated through the distribution partner's publicity team.
For distribution and production inquiries, please contact: